英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

dyne    
n. 达因[力量的单位]

达因[力量的单位]

dyne
n 1: a unit of force equal to the force that imparts an
acceleration of 1 cm/sec/sec to a mass of 1 gram

Dyne \Dyne\, n. [Formed fr. Gr. ? power. See {Dynamic}.]
(Physics)
The unit of force, in the C. G. S. (Centimeter Gram Second)
system of physical units; that is, the force which, acting on
a gram for a second, generates a velocity of a centimeter per
second.
[1913 Webster]


请选择你想看的字典辞典:
单词字典翻译
dyne查看 dyne 在百度字典中的解释百度英翻中〔查看〕
dyne查看 dyne 在Google字典中的解释Google英翻中〔查看〕
dyne查看 dyne 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Dyne Therapeutics - A biotechnology company developing nucleic acid . . .
    Culture and careers Our commitment to people living with neuromuscular diseases is our greatest strength Hear our Dynamos share their perspective on what makes Dyne a special place to work Learn more
  • DYN Stock Price | Dyne Therapeutics Inc. Stock Quote (U. S. : Nasdaq . . .
    DYN | Complete Dyne Therapeutics Inc stock news by MarketWatch View real-time stock prices and stock quotes for a full financial overview
  • Dyne - Wikipedia
    The dyne (symbol: dyn; from Ancient Greek δύναμις (dúnamis) 'power, force') is a derived unit of force specified in the centimetre–gram–second (CGS) system of units, a predecessor of the modern SI
  • DYN Stock Price Quote | Morningstar
    See the latest Dyne Therapeutics Inc Ordinary Shares stock price (DYN:XNAS), related news, valuation, dividends and more to help you make your investing decisions
  • Dyne Therapeutics (DYN) Stock Price, News Analysis
    Should You Buy or Sell Dyne Therapeutics Stock? Get The Latest DYN Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat
  • Dyne Submits BLA to FDA for z-rostudirsen (DYNE-251) in Duchenne . . .
    Today, Dyne Therapeutics announced that the company has submitted a Biologics License Application (BLA) to the U S Food and Drug Administration (FDA) for zeleciment rostudirsen (z-rostudirsen, DYNE-251) for individuals living with Duchenne who are amenable to exon 51 skipping Z-rostudirsen is an investigational exon skipping therapy bound to an antigen-binding fragment (Fab) to help the
  • Dyne Submits BLA for Z-Rostudirsen in Exon 51 Skipping Duchenne . . .
    Dyne Therapeutics has submitted a biologics license application (BLA) to the FDA seeking accelerated approval of zeleciment rostudirsen (z-rostudirsen; formerly DYNE-251) for patients with Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping, marking a major regulatory milestone for the investigational exon-skipping therapy 1 The submission is supported by findings from the phase 1
  • Dyne readies FDA push after DMD exon 51 med excels in trial
    The drug “has the potential to transform the care of those living with DMD amenable to exon 51 skipping,” Dyne CEO John Cox said in a statement





中文字典-英文字典  2005-2009